This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Anchor Therapeutics Inc. (formerly Ascent Therapeutics; developing pepducin drug candidates that selectively target G protein coupled receptors) has raised $10mm through its Series B financing led by returning shareholders TVM Capital, HealthCare Ventures, and the Novartis Option Fund. The company says that other investors may add money to the round.
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?